Digital diplomatic crisis communication: diplomatic signalling and crisis narratives in an age of real – time governance by Cassidy, J

Mathematics for mechanical engineering technicians/ by 432814 Cassidy, J.

Hydrology for engineers and planners / by 211725 Hjelmfelt, A. T., Cassidy, J. J.

Investigation of the strength of beef bone by Cassidy, J. E, Monasterio, E. R

Get full text

The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex interventi... by Walker, J, Cassidy, J, Sharpe, M

The third symptom management research trial in oncology (SMaRT oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disor... by Walker, J, Cassidy, J, Sharpe, M

Public diplomacy in the digital age by Bjola, C, Cassidy, J, Manor, I

A pilot study of subjective well-being in colorectal cancer patients and their caregivers by Graham J, Spiliopoulou P, Arbuckle R, Bridge JA, Cassidy J

Get full text

THE IMPACT OF MILD RENAL IMPAIRMENT ON THE TOXICITY OF OXALIPLATIN AND FLUOROPYRIMIDINE REGIMENS: EXPERIENCE IN THE MRC COIN TRIAL by Madi, A, Wilson, R, Adams, R, Seymour, M, Meade, A, Cassidy, J, Fisher, D, Kenny, S, Kaplan, R, Maughan, T

INTERMITTENT VS. CONTINUOUS OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN THE MRC COIN TRIAL IN ADVANCED COLORECTAL CANCER: UPDATED EFFICACY RESULTS, QUALITY OF LIFE AND POTENTIAL P... by Adams, R, Wilson, R, Seymour, M, Meade, A, Madi, A, Cassidy, J, Fisher, D, Kenny, S, Kaplan, R, Maughan, T

Intermittent versus continuous oxaliplatin-based combination chemotherapy in patients with advanced colorectal cancer: a randomised non-inferiority trial (MRC COIN) by Adams, R, Wilson, R, Seymour, M, Meade, A, Madi, A, Cassidy, J, Fisher, D, Kenny, S, Kaplan, R, Maughan, T

Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. by Espie, C, Fleming, L, Cassidy, J, Samuel, L, Taylor, L, White, C, Douglas, N, Engleman, H, Kelly, H, Paul, J

Predictive and prognostic value of gender in early-stage colon cancer: A pooled analysis of 33,345 patients from the ACCENT database by Cheung, W, Shi, Q, O'Connell, M, Cassidy, J, Blanke, C, Kerr, D, Van Cutsem, E, Alberts, SR, Yothers, G, Sargent, J, Grp, A

The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database. by Cheung, W, Shi, Q, O'Connell, M, Cassidy, J, Blanke, C, Kerr, D, Meyers, J, Van Cutsem, E, Alberts, SR, Yothers, G, Sargent, D

Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. by Seymour, L, Ferry, DR, Kerr, D, Rea, D, Whitlock, M, Poyner, R, Boivin, C, Hesslewood, S, Twelves, C, Blackie, R, Schatzlein, A, Jodrell, D, Bissett, D, Calvert, H, Lind, M, Robbins, A, Burtles, S, Duncan, R, Cassidy, J

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. by Cassidy, J, Douillard, J, Twelves, C, McKendrick, J, Scheithauer, W, Bustová, I, Johnston, P, Lesniewski-Kmak, K, Jelic, S, Fountzilas, G, Coxon, F, Díaz-Rubio, E, Maughan, T, Malzyner, A, Bertetto, O, Beham, A, Figer, A, Dufour, P, Patel, K, Cowell, W, Garrison, L

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial by Iveson, T, Kerr, R, Saunders, M, Cassidy, J, Hollander, N, Tabernero, J, Haydon, A, Glimelius, B, Harkin, A, Allan, K, McQueen, J, Scudder, C, Boyd, K, Briggs, A, Waterston, A, Medley, L, Wilson, C, Ellis, R, Essapen, S, Dhadda, A, Harrison, M, Falk, S, Raouf, S, Rees, C, Olesen, R, Propper, D, Bridgewater, J, Azzabi, A, Farrugia, D, Webb, A, Cunningham, D, Hickish, T, Weaver, A, Gollins, S, Wasan, H, Paul, J